核子醫學部網站logo圖示

 

  History Principle

 

Historic development of Department of Nuclear Medicine

 

      The Department of Nuclear Medicine was established in 1972. Professor Shin- Hwa Yeh, a pioneer of Nuclear Medicine in Taiwan, was the first to be a director of the department. Initially, there were 15 staffs and 2 liner scanner for imaging in the department. Only bone, liver and spleen, brain and thyroid gland scintigraphy could be performed. Up to now, there are 34 staffs, 5 angular γ-camera, one scanner of positron emission tomography (PET) and one set of cyclotron in the department. Thirty-one items of imaging and 28 items of radioimmunoassy (RIA) can be done routinely. In addition, there are 3 special wards for management the patients with residual or recurrent thyroid carcinoma. The following is a list of milestones in the development of the Department of Nuclear Medicine since 1972.

1972: Nuclear Medicine Center is set up; the director is Professor Shin-Hwa Yeh.

1973: Bone, brain (Tc-99m), liver and spleen and thyroid gland scintigraphy are applied for clinical use.

1973~1975: RIA for detection the titers of hepatitis B markers, thyroid hormones, α-FP and CEA are applied for clinical use.

1975: Dr. Keh-Chi Chen becomes a director of the center.

1977: Dr. Yeon-Biing Lee takes office the director of the center.

1979: Nuclear Medicine Center reorganizes as the Department of Nuclear Medicine; Professor Shin-Hwa Yeh is the director.

1980: I-131 thyroid ablation therapy is applied for clinical use.

1982: Dr. William Chen becomes a director of the Department of Nuclear Medicine; the first angular γ-camera is purchased; renal and lung perfusion scintigraphy are applied for clinical use.

1983: Tl-201 myocardial perfusion scintigraphy is applied for clinical use.

1986: The first-pass radionuclide angiography and equilibrium radionuclide angiography are applied for clinical use.

1987: Tc-99m HMPAO brain scan is applied for clinical use.

1987~1990: RIA for detection the titers of tumor markers including CA153, CA125, CA199, SCC, Vit B12 and ferretin are applied for clinical use.

1990: Lung ventilation scan with Xe-133 is applied for clinical use.

1991: RIA for detection the titers of PSA and PAP are applied for clinical use.

1995: Dr. William Chen becomes the chairman of the Society of Nuclear Medicine of R.O.C.

1996: The first combine conferrence of Nuclear Medicine between China Continent and Taiwan is held in Taipei; Dr. William Chen is the chairman.

1998: Dr. Wen-Shen Huang becomes a director of the department.

1999: Tc-99m MIBI myocardial perfusion scintigraphy is applied for clinical use.

2000: Tc-99m Trodat-1 brain scan is applied for clinical use; RIA for detection the titers of β2 microglobulin and Ach-R Ab are applied for clinical use.

2001: The Department of Nuclear Medicine is moved to Nei-Hu; a SPECT/CT γ-camera is purchased.

2002: I-123 ADAM brain scan is applied for animal study.

2003: Dr. Cheng-Yi Cheng becomes a director of the department; PET center is found.

2005: We became the first hospital approval for manufacturing F-18 FDG in Taiwan

2006: We cooperated with several medical centers in Taiwan and the world; we also held the 6th cyclotron club together with Tzu-Chi hospital.

2006: Established the PACS system and used the digital image for interpretation.

2006: We invented the F-18 FADAM and host the first human clinical trial of F-18 FADAM in the world.

2007: We hosted the international symposium of radiation accident, invited several scholars from Japan and Korea to discuss the issue of radiation protection.

2007: We run the annual maneuver of radiation accident with Tai-power nuclear power plant and the result is a real success.

2008: We signed a memorandum of agreement in communication and cooperation with National Institute of Radiological Sciences (NIRS) of Japan and Korea Institute of Radiological and Medical Sciences (KIRAMS) of Korea.

2009: We run the annual maneuver of radiation accident with Tai-power nuclear power plant and the result is a real success.

2014: Dr. Cheng-Yi Cheng becomes the chairman of the Society of Nuclear Medicine of R.O.C.

2014:Discovery PET/CT 710 system is purchase and applied for clinical used.